OT: PULM v2.0 | CALA Message Board Posts

Calithera Biosciences, Inc.

  CALA website

CALA   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  2589 of 2601  at  1/13/2019 4:35:21 PM  by

JoeFlow


 In response to msg 2587 by  JoeFlow
view thread

Re: OT: PULM v2.0

 not going to pay for original article but here's link to "supporting information": 
 
 
hoping this will be covered by PULM's existing patents because I remember reading their particles are made of amino acids, salts with proprietary methods, etc..  Science Daily article cites the particles used with mRNA are: "charged polymers called hyperbranched poly (beta amino esters)" - not amino acids so that might be a stretch....  also hard to say if this new mRNA application uses the same procedures to make the particles as PULM's iSPERSE tech without having the full article.  Maybe PULM will have something to say about this on their website or "earnings" report.  either way, the mRNA method is a long way from getting into clinic.
 
One point of concern may be that one of the other co-authors, Kevin Kauffman, is an employee at Verseau Therapeutics.  Another co-author, Daniel G. Anderson, is on BoD and is a co-founder along with Langer....  not sure about the other co-authors but nobody from PULM is an author.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 170
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us    Contact Us    Follow Us on Twitter    Members Directory    Help Center    Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
2003-2018 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...